The Consolidated Appropriations Act, a bill signed into law in December of 2022, contains the FDA Omnibus Reform Act of 2022 (FDORA), an act that will impact clinical research in many ways from decentralized trial guidance and digital health technologies guidance to BIMO inspection updates and changes to the accelerated approval process.

Get Your Copy Now

When you need direct access to physicians and their known patients or research practice management solutions to accelerate your clinical trials, there’s Only Elligo.

Contact Us